Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'WHITEHOUSE PJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 106 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Whitehouse, PJ
      The end of Alzheimer disease II: Commentary on "Decisions to treat or not to treat pneumonia in demented psychogeriatric nursing home patients"

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    2. Whitehouse, PJ
      The end of Alzheimer disease

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    3. Whitehouse, PJ
      Editorial commentary

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    4. Post, SG; Stuckey, FC; Whitehouse, PJ; Ollerton, S; Durkin, C; Robbins, D; FallCreek, SJ
      A focus group on cognition-enhancing medications in Alzheimer disease: Disparities between professionals and consumers

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    5. Whitehouse, PJ; Ballenger, JF; Sadowsky, J; Gaines, AD
      Illness and culture in the postmodern age.

      HASTINGS CENTER REPORT
    6. Doody, RS; Stevens, JC; Beck, C; Dubinsky, RM; Kaye, JA; Gwyther, L; Mohs, RC; Thal, LJ; Whitehouse, PJ; DeKosky, ST; Cummings, JL
      Practice parameter: Management of dementia (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology

      NEUROLOGY
    7. Whitehouse, PJ
      Regulatory issues concerning behavioral and psychological symptoms of dementia: An overview

      INTERNATIONAL PSYCHOGERIATRICS
    8. Whitehouse, PJ
      Editorial commentary

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    9. Whitehouse, PJ
      New models for a new age

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    10. Whitehouse, PJ
      Harmonization of dementia drug guidelines (United States and Europe): A report of the International Working Group for the Harmonization for Dementia Drug Guidelines

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    11. Whitehouse, PJ; Bendezu, E; FallCreek, S; Whitehouse, C
      Intergenerational community schools: A new practice for a new time

      EDUCATIONAL GERONTOLOGY
    12. Whitehouse, PJ
      Cholinesterase inhibitors in Alzheimer's disease - Are they worth the cost?

      CNS DRUGS
    13. Jobst, KA; Shostak, D; Whitehouse, PJ
      Diseases of meaning, manifestations of health, and metaphor

      JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
    14. Whitehouse, PJ
      Managed care and complementary and alternative medicine: Lessons from the past and suggestions for the future

      JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
    15. Whitehouse, PJ
      Alzheimer's disease: past, present, and future

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    16. Hinze, SW; Gaines, AD; Lerner, AJ; Whitehouse, PJ
      An interdisciplinary response to the Reagan Research Institute Report on Women and Alzheimer's disease

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    17. Whitehouse, PJ; Arizaga, R; Brodaty, H; Gauthier, S; Graham, N; Green, RC; Homma, A; Mangone, C; Senanarong, V; Xu, XH
      Placebos in clinical trials in Alzheimer disease: An international discussion

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    18. Kawas, CH; Clark, CM; Farlow, MR; Knopman, DS; Marson, D; Morris, JC; Thal, LJ; Whitehouse, PJ
      Clinical trials in Alzheimer disease: Debate on the use of placebo controls

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    19. Ballenger, JF; Nelson, JL; Whitehouse, PJ
      Beyond "progress" in the history of Alzheimer disease

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    20. Post, SG; Whitehouse, PJ; Nelson, JL; Sachs, GA
      Alzheimer disease ethics: A continuing area of public interest

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    21. Cohen, CA; Whitehouse, PJ; Post, SG; Gauthier, S; Eberhart, A; LeDuc, L
      Ethical issues in Alzheimer disease: The experience of a national Alzheimer Society Task Force

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    22. Erkinjuntti, T; Sawada, T; Whitehouse, PJ
      The Osaka Conference on Vascular Dementia 1998

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    23. Whitehouse, PJ
      The ecomedical disconnection syndrome

      HASTINGS CENTER REPORT
    24. Ballenger, JF; Whitehouse, PJ
      When research will not follow where questions lead: The boundaries of dementia research

      GERONTOLOGIST
    25. Whitehouse, PJ; Post, SG
      Ethical problems in the use of antidementia drugs - In reply

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    26. Whitehouse, PJ
      Interesting conflicts and conflicting interests

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    27. SMITH AL; WHITEHOUSE PJ
      PROGRESS IN THE MANAGEMENT OF ALZHEIMERS-DISEASE

      Hospital practice
    28. Koss, E; Patterson, MB; Mack, JL; Smyth, KA; Whitehouse, PJ
      Reliability and validity of the Tinkertoy Test in evaluating individuals with Alzheimer's disease

      CLINICAL NEUROPSYCHOLOGIST
    29. Whitehouse, PJ; Harris, G
      The inter-generational transmission of eating disorders

      EUROPEAN EATING DISORDERS REVIEW
    30. POTTER V; WHITEHOUSE PJ
      DEEP AND GLOBAL BIOETHICS FOR A LIABLE 3RD-MILLENNIUM

      The Scientist
    31. WHITEHOUSE PJ
      THE CHOLINERGIC DEFICIT IN ALZHEIMERS-DISEASE

      The Journal of clinical psychiatry
    32. WHITEHOUSE PJ
      DONEPEZIL

      Medicamentos de actualidad
    33. KITAMURA Y; SHIMOHAMA S; KAMOSHIMA W; OTA T; MATSUOKA Y; NOMURA Y; SMITH MA; PERRY G; WHITEHOUSE PJ; TANIGUCHI T
      ALTERATION OF PROTEINS REGULATING APOPTOSIS, BCL-2, BCL-X, BAX, BAK, BAD, ICH-1 AND CPP32, IN ALZHEIMERS-DISEASE

      Brain research
    34. KARLAWISH JHT; WHITEHOUSE PJ
      IS THE PLACEBO CONTROL OBSOLETE IN A WORLD AFTER DONEPEZIL AND VITAMIN-E

      Archives of neurology
    35. POST SG; WHITEHOUSE PJ
      EMERGING ANTIDEMENTIA DRUGS - A PRELIMINARY ETHICAL VIEW

      Journal of the American Geriatrics Society
    36. Post, SG; Whitehouse, PJ; Zinn, AB
      Genetics and the moral future of dementia care

      GENETIC TESTING FOR ALZHEIMER DISEASE
    37. Whitehouse, PJ
      Therapeutic interventions in Alzheimer disease - Implications of genetic advances

      GENETIC TESTING FOR ALZHEIMER DISEASE
    38. WHITEHOUSE PJ
      DONEPEZIL - A VIEWPOINT

      Drugs & aging
    39. WHITEHOUSE PJ
      READDRESSING OUR MORAL RELATIONSHIP TO NONHUMAN CREATURES - COMMENTARY ON A DIALOGUE ON SPECIES-SPECIFIC RIGHTS - HUMANS AND ANIMALS IN BIOETHICS

      CQ. Cambridge quarterly of healthcare ethics
    40. HAY JW; SANO M; WHITEHOUSE PJ
      THE COSTS AND SOCIAL BURDENS OF ALZHEIMER-DISEASE - WHAT CAN AND SHOULD BE DONE

      Alzheimer disease and associated disorders
    41. WHITEHOUSE PJ; REIDENBACH F
      GUIDELINES FOR EARLY IDENTIFICATION OF ALZHEIMER-DISEASE

      Alzheimer disease and associated disorders
    42. SMYTH KA; FERRIS SH; FOX P; HEYMAN A; HOLMES D; MORRIS JN; PHILLIPS CD; SCHULZ R; TERESI J; WHITEHOUSE PJ
      MEASUREMENT CHOICES IN MULTISITE STUDIES OF OUTCOMES IN DEMENTIA

      Alzheimer disease and associated disorders
    43. WHITEHOUSE PJ
      SLOWING THE PROGRESSION OF ALZHEIMERS-DISEASE - METHODOLOGY AND ETHICAL ISSUES - ROUND-TABLE HELD AT THE 5TH INTERNATIONAL-CONFERENCE ON ALZHEIMERS-DISEASE AND RELATED DISORDERS, JULY 24-29, 1996, OSAKA, JAPAN- INTRODUCTION

      Alzheimer disease and associated disorders
    44. WHITEHOUSE PJ
      PHARMACOECONOMICS OF DEMENTIA

      Alzheimer disease and associated disorders
    45. BODICK NC; WHITEHOUSE PJ; LEVKOFF S
      PHARMACOECONOMICS OF DEMENTIA - DISCUSSION

      Alzheimer disease and associated disorders
    46. LEBER P; POST SG; GREEN RC; WHITEHOUSE PJ; RABINS PV; LIEBLER ET; ROGERS J; MALFLIET TOT
      SLOWING THE PROGRESSION OF ALZHEIMER-DISEASE - ETHICAL ISSUES - GENERAL DISCUSSION

      Alzheimer disease and associated disorders
    47. WHITEHOUSE PJ
      REPORT OF THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OF DEMENTIA DRUG GUIDELINES - INTRODUCTION

      Alzheimer disease and associated disorders
    48. WHITEHOUSE PJ
      THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OF DEMENTIA DRUG GUIDELINES - PAST, PRESENT, AND FUTURE

      Alzheimer disease and associated disorders
    49. POST SG; BEERMAN B; BRODATY H; GAINES AW; GAUTHIER SG; GELDMACHER DS; HILL S; HOMMA A; ROSSOR MN; WHITEHOUSE PJ; WINBLAD B
      ETHICAL ISSUES IN DEMENTIA DRUG DEVELOPMENT - POSITION PAPER FROM THEINTERNATIONAL WORKING GROUP ON HARMONIZATION OF DEMENTIA DRUG GUIDELINES

      Alzheimer disease and associated disorders
    50. HARVEY RJ; SCIULLI CG; MASON RM; WHITEHOUSE PJ
      INFORMATION TECHNOLOGY AND THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OF DEMENTIA DRUG GUIDELINES

      Alzheimer disease and associated disorders
    51. WHITEHOUSE PJ; ORGOGOZO JM; BECKER RE; GAUTHIER S; PONTECORVO M; ERZIGKEIT H; ROGERS S; MOHS RC; BODICK N; BRUNO G; DALBIANCO P
      QUALITY-OF-LIFE ASSESSMENT IN DEMENTIA DRUG DEVELOPMENT - POSITION PAPER FROM THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OF DEMENTIA DRUG GUIDELINES

      Alzheimer disease and associated disorders
    52. FERRIS SH; MACKELL JA; MOHS R; SCHNEIDER LS; GALASKO D; WHITEHOUSE PJ; SCHMITT FA; SANO M; THOMAS RG; ERNESTO C; GRUNDMAN M; SCHAFER K; THAL LJ
      A MULTICENTER EVALUATION OF NEW TREATMENT EFFICACY INSTRUMENTS FOR ALZHEIMERS-DISEASE CLINICAL-TRIALS - OVERVIEW AND GENERAL RESULTS

      Alzheimer disease and associated disorders
    53. PATTERSON MB; MACK JL; MACKELL JA; THOMAS R; TARIOT P; WEINER M; WHITEHOUSE PJ
      A LONGITUDINAL-STUDY OF BEHAVIORAL PATHOLOGY ACROSS 5 LEVELS OF DEMENTIA SEVERITY IN ALZHEIMERS-DISEASE - THE CERAD BEHAVIOR RATING-SCALE FOR DEMENTIA

      Alzheimer disease and associated disorders
    54. KOSS E; WEINER M; ERNESTO C; COHENMANSFIELD J; FERRIS SH; GRUNDMAN M; SCHAFER K; SANO M; THAL LJ; THOMAS R; WHITEHOUSE PJ
      ASSESSING PATTERNS OF AGITATION IN ALZHEIMERS-DISEASE PATIENTS WITH THE COHEN-MANSFIELD AGITATION INVENTORY

      Alzheimer disease and associated disorders
    55. GELDMACHER DS; LERNER AJ; VOCI JM; NOELKER EA; SOMPLE LC; WHITEHOUSE PJ
      TREATMENT OF FUNCTIONAL DECLINE IN ADULTS WITH DOWN-SYNDROME USING SELECTIVE SEROTONIN-REUPTAKE INHIBITOR DRUGS

      Journal of geriatric psychiatry and neurology
    56. WHITEHOUSE PJ
      ALZHEIMERS-DISEASE IN SENILE DEMENTIA - LOSS OF NEURONS IN THE BASAL FOREBRAIN - AUTHORS RETROSPECTIVE

      International journal of geriatric psychiatry
    57. SEHGAL AR; GREY SF; DEOREO PB; WHITEHOUSE PJ
      PREVALENCE, RECOGNITION, AND IMPLICATIONS OF MENTAL IMPAIRMENT AMONG HEMODIALYSIS-PATIENTS

      American journal of kidney diseases
    58. POST SG; WHITEHOUSE PJ
      GENETIC TESTING FOR ALZHEIMER-DISEASE - REPLY

      JAMA, the journal of the American Medical Association
    59. POST SG; WHITEHOUSE PJ; BINSTOCK RH; BIRD TD; ECKERT SK; FARRER LA; FLECK LM; GAINES AD; JEUNGST ET; KARLINSKY H; MILES S; MURRAY TD; QUAID KA; RELKIN NR; ROSES AD; STGEORGEHYSLOP PH; SACHS GA; STEINBOCK B; TRUSCHKE EF; ZINN AB
      THE CLINICAL INTRODUCTION OF GENETIC TESTING FOR ALZHEIMER-DISEASE - AN ETHICAL PERSPECTIVE

      JAMA, the journal of the American Medical Association
    60. WHITEHOUSE PJ; JUENGST E; MEHLMAN M; MURRAY TH
      ENHANCING COGNITION IN THE INTELLECTUALLY INTACT

      The Hastings Center report
    61. WHITEHOUSE PJ; SCIULLI CG; MASON RM
      DEMENTIA DRUG DEVELOPMENT - USE OF INFORMATION-SYSTEMS TO HARMONIZE GLOBAL DRUG DEVELOPMENT

      Psychopharmacology bulletin
    62. WHITEHOUSE PJ
      GENESIS OF ALZHEIMERS-DISEASE

      Neurology
    63. GELDMACHER DS; WHITEHOUSE PJ
      DIFFERENTIAL-DIAGNOSIS OF ALZHEIMERS-DISEASE

      Neurology
    64. PATTERSON MB; MACK JL; GELDMACHER DS; WHITEHOUSE PJ
      EXECUTIVE FUNCTIONS AND ALZHEIMERS-DISEASE - PROBLEMS AND PROSPECTS

      European journal of neurology
    65. FERRIS SH; WHITEHOUSE PJ
      ADVANCES IN DRUG DEVELOPMENT - THE ROLE OF ALZHEIMER-DISEASE AND ASSOCIATED DISORDERS

      Alzheimer disease and associated disorders
    66. WHITEHOUSE PJ; MORRIS JC
      DISCLOSURE OF FINANCIAL INTEREST - A NEW POLICY FOR ALZHEIMER-DISEASEAND ASSOCIATED DISORDERS

      Alzheimer disease and associated disorders
    67. WHITEHOUSE PJ; POST SG; SACHS GA
      DEMENTIA CARE AT THE END OF LIFE - EMPIRICAL-RESEARCH AND INTERNATIONAL COLLABORATION

      Alzheimer disease and associated disorders
    68. GELDMACHER DS; WHITEHOUSE PJ
      CURRENT CONCEPTS - EVALUATION OF DEMENTIA

      The New England journal of medicine
    69. WHITEHOUSE PJ; GELDMACHER DS
      EVALUATION OF SUSPECTED DEMENTIA - REPLY

      The New England journal of medicine
    70. WHITEHOUSE PJ
      FUTURE-PROSPECTS FOR ALZHEIMERS-DISEASE THERAPY - ETHICAL AND POLICY ISSUES FOR THE INTERNATIONAL COMMUNITY

      Acta neurologica Scandinavica
    71. WHITEHOUSE PJ; VOCI J
      THERAPEUTIC TRIALS IN ALZHEIMERS-DISEASE

      Current opinion in neurology
    72. GILMORE GC; WHITEHOUSE PJ
      CONTRAST SENSITIVITY IN ALZHEIMERS-DISEASE - A 1-YEAR LONGITUDINAL ANALYSIS

      Optometry and vision science
    73. FERRIS SH; HASEGAWA K; HOMMA A; KHACHATURIAN ZS; POST S; ROSSOR M; WHITEHOUSE PJ
      INTERNATIONAL EFFORTS TO IMPROVE ALZHEIMER-DISEASE TREATMENT

      Alzheimer disease and associated disorders
    74. FERRIS SH; WHITEHOUSE PJ
      THE YEAR IN REVIEW

      Alzheimer disease and associated disorders
    75. WHITEHOUSE PJ; KALARIA RN
      NICOTINIC RECEPTORS AND NEURODEGENERATIVE DEMENTING DISEASES - BASIC RESEARCH AND CLINICAL IMPLICATIONS

      Alzheimer disease and associated disorders
    76. WHITEHOUSE PJ
      SHOULD WE DIFFERENTIATE SUBTYPES OF ALZHEIMER-DISEASE

      Alzheimer disease and associated disorders
    77. RIPICH DN; PETRILL SA; WHITEHOUSE PJ; ZIOL EW
      GENDER DIFFERENCES IN LANGUAGE OF AD PATIENTS - A LONGITUDINAL-STUDY

      Neurology
    78. SHIMOHAMA S; FUJIMOTO S; MATSUSHIMA H; TAKENAWA T; TANIGUCHI T; PERRY G; WHITEHOUSE PJ; KIMURA J
      ALTERATION OF PHOSPHOLIPASE C-DELTA PROTEIN LEVEL AND SPECIFIC ACTIVITY IN ALZHEIMERS-DISEASE

      Journal of neurochemistry
    79. SHIMOHAMA S; FUJIMOTO S; CHACHIN M; TANIGUCHI T; PERRY G; WHITEHOUSE PJ; KIMURA J
      ALTERATIONS OF LOW-MOLECULAR-WEIGHT ACID-PHOSPHATASE PROTEIN LEVEL INALZHEIMERS-DISEASE

      Brain research
    80. SHIMOHAMA S; PERRY G; RICHEY P; PRAPROTNIK D; TAKENAWA T; FUKAMI K; WHITEHOUSE PJ; KIMURA J
      CHARACTERIZATION OF THE ASSOCIATION OF PHOSPHOLIPASE C-DELTA WITH ALZHEIMER NEUROFIBRILLARY TANGLES

      Brain research
    81. WHITEHOUSE PJ; DEAL WE
      SITUATED BEYOND MODERNITY - LESSONS FOR ALZHEIMERS-DISEASE RESEARCH

      Journal of the American Geriatrics Society
    82. HIGH DM; POST SG; WHITEHOUSE PJ
      ETHICAL AND LEGAL ISSUES IN ALZHEIMER-DISEASE RESEARCH - INTRODUCTION

      Alzheimer disease and associated disorders
    83. POST SG; RIPICH DN; WHITEHOUSE PJ
      DISCOURSE ETHICS - RESEARCH, DEMENTIA, AND COMMUNICATION

      Alzheimer disease and associated disorders
    84. HIGH DM; WHITEHOUSE PJ; POST SG; BERG L
      GUIDELINES FOR ADDRESSING ETHICAL AND LEGAL ISSUES IN ALZHEIMER-DISEASE RESEARCH - A POSITION PAPER

      Alzheimer disease and associated disorders
    85. PATTERSON MB; WHITEHOUSE PJ
      BEHAVIORAL SYMPTOMS IN DEMENTIA - THEORIES AND THERAPIES

      Alzheimer disease and associated disorders
    86. WHITEHOUSE PJ
      NATIONAL INSTITUTE ON AGING SPECIAL CARE UNITS

      Alzheimer disease and associated disorders
    87. MARTIN RJ; GWYTHER LP; WHITEHOUSE PJ
      SPECIAL CARE UNIT RESEARCH - ETHICAL ISSUES

      Alzheimer disease and associated disorders
    88. WHITEHOUSE PJ
      PHARMACOTHERAPY FOR ALZHEIMERS-DISEASE (VOL 10, PG 341, 1994)

      Clinics in geriatric medicine
    89. WHITEHOUSE PJ; GELDMACHER DS
      PHARMACOTHERAPY FOR ALZHEIMERS-DISEASE

      Clinics in geriatric medicine
    90. WHITEHOUSE PJ
      ALZHEIMERS-DISEASE UPDATE - FOREWORD

      Clinics in geriatric medicine
    91. ROSENBERG CE; LEE J; ROWLAND D; WHITEHOUSE PJ
      24-HOUR CORTISOL CIRCADIAN-RHYTHM IN ALZHEIMERS-DISEASE - COMPARISON WITH NORMAL SUBJECTS

      Neurobiology of aging
    92. SHIMOHAMA S; MATSUSHIMA H; FUJIMOTO S; TSUJI T; TANIGUCHI T; TAKENAWA T; PERRY G; RICHEY P; WHITEHOUSE PJ; KIMURA J
      ABNORMALITIES OF PHOSPHOLIPASE C-DELTA IN ALZHEIMERS-DISEASE

      Neurobiology of aging
    93. WHITEHOUSE PJ; PAX AB; KALARIA RN
      HETEROGENEITY OF CORTICAL NICOTINIC RECEPTORS AND DIFFERENTIAL CHANGES IN ALZHEIMERS-DISEASE

      Neurobiology of aging
    94. KALARIA RN; HOMAYOUN P; WHITEHOUSE PJ
      NICOTINIC CHOLINERGIC RECEPTORS ASSOCIATED WITH MAMMALIAN CEREBRAL VESSELS

      Journal of the autonomic nervous system
    95. DRESSER R; WHITEHOUSE PJ
      THE INCOMPETENT PATIENT ON THE SLIPPERY SLOPE

      The Hastings Center report
    96. LANSKA DJ; CURRIER RD; COHEN M; GAMBETTI P; SMITH EE; BEBIN J; JACKSON JF; WHITEHOUSE PJ; MARKESBERY WR
      FAMILIAL PROGRESSIVE SUBCORTICAL GLIOSIS

      Neurology
    97. LERNER AJ; KOSS E; PATTERSON MB; OWNBY RL; HEDERA P; FRIEDLAND RP; WHITEHOUSE PJ
      CONCOMITANTS OF VISUAL HALLUCINATIONS IN ALZHEIMERS-DISEASE

      Neurology
    98. SHIMOHAMA S; PERRY G; RICHEY P; TAKENAWA T; WHITEHOUSE PJ; MIYOSHI K; SUENAGA T; MATSUMOTO S; NISHIMURA M; KIMURA J
      ABNORMAL ACCUMULATION OF PHOSPHOLIPASE C-DELTA IN FILAMENTOUS INCLUSIONS OF HUMAN NEURODEGENERATIVE DISEASES

      Neuroscience letters
    99. KENNEDY JS; STRAUSS ME; SMYTH KA; WHITEHOUSE PJ
      THE RELATIONSHIP OF CLINICAL PSYCHOPATHOLOGICAL RATING AND COGNITIVE-FACTORS TO CLINICAL DEMENTIA STAGING

      Progress in neuro-psychopharmacology & biological psychiatry
    100. MACK JL; SCHNELL AH; PATTERSON MB; WHITEHOUSE PJ
      PERFORMANCE OF SUBJECTS WITH PROBABLE ALZHEIMER-DISEASE AND NORMAL ELDERLY CONTROLS ON THE GOLLIN INCOMPLETE PICTURES TEST

      Perceptual and motor skills


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 12:15:18